发明名称 |
B-Cell Reduction Using CD37-Specific and CD20-Specific Binding Molecules |
摘要 |
<p>594275 Disclosed is a humanized CD37-specific binding protein comprising: (a) human light chain framework regions, a light chain CDR1 comprising an amino acid sequence of SEQ ID NO:61, or 62, a light chain CDR2 comprising an amino acid sequence of SEQ ID NO:64, and a light chain CDR3 comprising an amino acid sequence of SEQ ID NO:66; and (b) human heavy chain framework regions, a heavy chain CDR1 comprising an amino acid sequence of SEQ ID NO:63, a heavy chain CDR2 comprising an amino acid sequence of SEQ ID NO:65, and a heavy chain CDR3 comprising an amino acid sequence of SEQ ID NO: 67 or 68.</p> |
申请公布号 |
NZ594275(A) |
申请公布日期 |
2013.04.26 |
申请号 |
NZ20060594275 |
申请日期 |
2006.07.25 |
申请人 |
EMERGENT PRODUCT DEVELOPMENT SEATTLE, LLC |
发明人 |
PETER ARMSTRONG THOMPSON;WILLIAM BRADY;MARTHA SUSAN HAYDEN-LEDBETTER;SANDY ALEXANDER SIMON;LAURA SUE GROSMAIRE;JEFFREY A |
分类号 |
C12N5/10;A61K39/395;A61P21/04;A61P35/00;A61P37/00;C07K16/28;C07K16/46;C12N15/13;C12N15/85 |
主分类号 |
C12N5/10 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|